2017 - CIRTA


This page contains exclusive content for the member of the following sections: TTS, ITA. Log in to view.

7- Infections and Other Lessons Learned after IntestineTransplantation

32.3 - One year incidence of infection in intestine transplant recipients at a single center

Presenter: Jared, Clouse, Indianapolis, United States
Authors: Jared Clouse, Chandrashekhar Kubal, Jonathan Fridell, Burcin Ekser, Richard Mangus

One year incidence of infection in intestine transplant recipients at a single center

Jared Clouse1, Chandrashekhar A. Kubal1, Jonathan A. Fridell1, Burcin Ekser1, Richard S. Mangus1.

1Surgery, Indiana University School of Medicine, Indianapolis, IN, United States

Introduction: This study reports the infection rate, location of infection, and pathogen causing bacterial, fungal, or viral infections in intestine transplant recipients during the first year post-transplant at an active transplant center. Additional risk for infection was assessed based on simultaneous inclusion of the liver or colon as a part of the intestine transplant.

Methods: Records from a single transplant center were reviewed for patients receiving an intestine transplant. Positive cultures and pathology reports were used to diagnose bacterial, fungal, and viral infections and also to determine location and infectious agent. For analysis, patients were grouped by age (pediatric or adult).

Results: During the study period, 236 intestine transplants were performed, 184 adult and 52 pediatric patients.

In adults, one year bacterial, fungal, and viral infection rates were 91%, 47%, and 29%, respectively. The most commonly infected sites were the urinary tract and bloodstream. Coagulase-negative Staphylococcus was the most commonly isolated pathogen and found in 48% of patients. Candida species were the most common fungal pathogens and seen in 42% of all patients, and in 89% of patients who developed a fungal infection. Cytomegalovirus infections were present in 15% of transplant recipients. Bacterial and fungal bloodstream infections (BSI) developed in 72% of patients with a median time to first infection of 30 days.

Among pediatric patients, bacterial, fungal, and viral infection rates were 90%, 25%, and 75%, respectively. Vancomycin susceptible enterococci were the most common pathogens and isolated from 52% of patients. Candida species were the most common fungal pathogens and observed in 23% of patients. Upper respiratory viral infections were common (44%) and cytomegalovirus infection rate was 17%. The most common sites of infection were bloodstream, urinary, and upper respiratory tract. The median days to the first BSI was 38 days.

Conclusion: Overall, 91% of adult and 90% of pediatric intestine transplant patients had a bacterial infection in the first year post-transplant. Opportunistic fungal and viral infections were also common. Age, gender, race, or liver inclusion did not have a significant impact on the development of a BSI or median time to first BSI. Colon inclusion significantly (p<.05) decreased the risk of developing a BSI in pediatric patients, while not having a significant impact on median days to first BSI or development of a BSI in adults.

The two tables below represent a portion of the data analyzed.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada